- Home
- TCBP vs NBY Comparison
TCBP vs NBY Comparison
Compare TCBP & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- NBY
- Stock Information
- Founded
- TCBP 2013
- NBY 2000
- Country
- TCBP United Kingdom
- NBY United States
- Employees
- TCBP N/A
- NBY N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- NBY
- Sector
- TCBP Health Care
- NBY
- Exchange
- TCBP Nasdaq
- NBY Nasdaq
- Market Cap
- TCBP 831.0K
- NBY 2.8M
- IPO Year
- TCBP 2022
- NBY 2007
- Fundamental
- Price
- TCBP $1.69
- NBY $0.64
- Analyst Decision
- TCBP Strong Buy
- NBY Strong Buy
- Analyst Count
- TCBP 1
- NBY 1
- Target Price
- TCBP $48.00
- NBY $0.85
- AVG Volume (30 Days)
- TCBP 632.6K
- NBY 69.8K
- Earning Date
- TCBP 11-25-2024
- NBY 05-08-2025
- Dividend Yield
- TCBP N/A
- NBY N/A
- EPS Growth
- TCBP N/A
- NBY N/A
- EPS
- TCBP N/A
- NBY N/A
- Revenue
- TCBP N/A
- NBY $13,844,000.00
- Revenue This Year
- TCBP N/A
- NBY N/A
- Revenue Next Year
- TCBP N/A
- NBY $11.73
- P/E Ratio
- TCBP N/A
- NBY N/A
- Revenue Growth
- TCBP N/A
- NBY 15.40
- 52 Week Low
- TCBP $1.43
- NBY $0.36
- 52 Week High
- TCBP $523.20
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- TCBP 28.01
- NBY 52.28
- Support Level
- TCBP $1.43
- NBY $0.55
- Resistance Level
- TCBP $2.19
- NBY $0.61
- Average True Range (ATR)
- TCBP 0.28
- NBY 0.04
- MACD
- TCBP 0.19
- NBY 0.00
- Stochastic Oscillator
- TCBP 20.57
- NBY 70.38
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.